Intellia Therapeutics, Inc Share Price
NASDAQ: NTLAHealthcare
Live Intellia Therapeutics, Inc Share Price Chart
O H L
Intellia Therapeutics, Inc Performance Overview
Days Range
▼
$11.87Low
$12.46High
Markets Today
| Previous Close | $12.26 |
|---|---|
| Open | $12.27 |
| Volume | 8,525,061 |
| Day's Range | $11.87 - $12.46 |
| 52W Range | $7.95 - $28.25 |
| Market Cap | $1.72 B |
Historical Performance
| 1M Returns | -8.58 |
|---|---|
| 3M Returns | -22.53 |
| 6M Returns | -7.68 |
| 1Y Returns | -22.13 |
| 5Y Returns | -91.82 |
| 10Y Returns | -36.31 |
Intellia Therapeutics, Inc Fundamentals
| Market Cap | $1.72 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $67.67 M |
| ROE TTM | -0.53 |
| EPS TTM | $-3.36 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.36 |
| EBITDA | $-431.22 M |
| Profit Margin | -609.85 |
| Market Cap | $1.72 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $67.67 M |
| ROE TTM | -0.53 |
| EPS TTM | $-3.36 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.36 |
| EBITDA | $-431.22 M |
| Profit Margin | -609.85 |
Intellia Therapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $16.63 M | $14.24 M | $13.78 M | $23.02 M | $15.05 M | $7.66 M |
| Gross Profit + | $16.63 M | $14.24 M | $13.78 M | $23.02 M | $15.05 M | $7.66 M |
| Operating Income | -$120.81 M | -$110.00 M | -$111.48 M | -$98.71 M | -$100.53 M | -$112.76 M |
| EBITDA | -$118.31 M | -$107.52 M | -$109.06 M | -$96.33 M | -$98.33 M | -$110.68 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $2.50 M | $2.47 M | $2.42 M | $2.38 M | $2.20 M | $2.08 M |
| Income Before Tax | -$114.33 M | -$101.25 M | -$101.32 M | -$95.79 M | -$96.23 M | -$106.63 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$114.33 M | -$101.25 M | -$101.32 M | -$95.79 M | -$96.23 M | -$106.63 M |
| Net Profit Margin | -687.61% | -710.81% | -735.19% | -416.15% | -639.49% | -1392.27% |
Intellia Therapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $10.00 K | $10.00 K | $12.00 K | $12.00 K | $12.00 K | $14.00 K |
| Reserve & Surplus | -$2.29 B | -$2.39 B | -$2.49 B | -$2.59 B | -$2.69 B | -$2.79 B |
| Non-Current Liabilities | $93.65 M | $88.14 M | $83.13 M | $66.85 M | $61.40 M | $50.07 M |
| Current Liabilities | $112.59 M | $95.50 M | $93.73 M | $103.88 M | $76.44 M | $79.39 M |
| Total Liabilities | $206.24 M | $183.64 M | $176.85 M | $170.73 M | $137.84 M | $129.46 M |
| Fixed Assets | $25.12 M | $22.81 M | $20.42 M | $17.67 M | $15.52 M | $15.06 M |
| Current Assets | $551.39 M | $495.94 M | $581.94 M | $527.71 M | $466.45 M | $527.83 M |
| Total Assets | $986.16 M | $898.89 M | $925.27 M | $842.13 M | $758.78 M | $857.16 M |
Intellia Therapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$114.33 M | -$101.25 M | -$101.32 M | -$95.79 M | -$96.23 M | -$106.63 M |
| Operating Cash Flow | -$148.93 M | -$99.62 M | -$76.90 M | -$69.28 M | -$117.35 M | -$83.11 M |
| Investing Cash Flow | $94.33 M | $106.91 M | -$741.00 K | $27.53 M | $66.31 M | -$141.57 M |
| Financing Cash Flow | $0 | $14.65 M | $114.86 M | $1.98 M | $33.57 M | $196.12 M |
| Change in Cash | -$54.60 M | $21.94 M | $37.22 M | -$39.77 M | -$17.47 M | -$28.57 M |
Intellia Therapeutics, Inc Return Calculator
The Intellia Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$795
Invested Amount$10,000
Est. Returns$-9,205
About Intellia Therapeutics, Inc
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
Popular Stocks
FAQs
What is the share price of Intellia Therapeutics, Inc today?
Intellia Therapeutics, Inc (NTLA) share price as of September 19, 2026 is $11.80. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Intellia Therapeutics, Inc?
Yes, Indian Investors can invest in the Intellia Therapeutics, Inc (NTLA) Share by opening an international trading account with Angel One.
How can I purchase Intellia Therapeutics, Inc shares in India?
Purchasing Intellia Therapeutics, Inc (NTLA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Intellia Therapeutics, Inc (NTLA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Intellia Therapeutics, Inc?
Yes, you can purchase fractional shares of Intellia Therapeutics, Inc (NTLA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Intellia Therapeutics, Inc?
The market capitalization of Intellia Therapeutics, Inc on September 19, 2026, is $1.72 B.
In which sector Intellia Therapeutics, Inc belongs?
Intellia Therapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Intellia Therapeutics, Inc stocks?
In order to invest in Intellia Therapeutics, Inc (NTLA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
